BETH ISRAEL DEACONESS MEDICAL CENTER, INC.;BETH ISRAEL DEACONESS MEDICAL CENTER;THE UNITED STATES OF AMERICA as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; INC.
The invention features compositions and methods for inhibiting the Pin1 protein, and the treatment of disorders characterized by elevated Pin1 levels.L'invention concerne des compositions et des procédés pour inhiber la protéine Pin1, et le traitement de troubles se caractérisant par des taux de Pin1 élevés.